May 15, 2012:
Carl Zeiss Meditec continues its profitable growth in first six months of financial year 2011/2012
Revenue 14.8 percent higher than previous year – EBIT margin grows to 14.1 percent
April 21, 2012:
Carl Zeiss Meditec Announces a US Clinical Trial of a new Minimally Invasive, All-Femto Laser Vision Correction Method
US FDA conditional approval received to initiate a clinical trial of the ReLEx smile procedure for the correction of myopia with the VisuMax Femtosecond Laser
April 13, 2012:
OPMI PENTERO 900 Surgical Microscope from Carl Zeiss Receives Prestigious red dot Award
Carl Zeiss Meditec to showcase award-winning microscope at the 2012 American Association of Neurological Surgeons
